FLU VACCINE FOR 1994-95 SHOULD KEEP TEXAS/36/91 AS A(H1N1) COMPONENT
FLU VACCINE FOR 1994-95 SHOULD KEEP TEXAS/36/91 AS A(H1N1) COMPONENT of the trivalent influenzae vaccine, FDA's Vaccine & Related Biological Products Advisory Committee decided Jan. 27. The recommendation to include the Texas/36/91 strain in the 1994- 95 vaccine was based on Centers for Disease Control and Prevention reports that no new variants of A(H1N1) have been detected since the last influenzae season.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth